Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannu Raunio

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|July 21, 2011
In silico toxicology - non-testing methodsHannu Raunio
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
In vitro screening of drug metabolism during drug development: can we trust the predictions?Olavi Pelkonen, Hannu Raunio
Personalized Medicine|May 17, 2018
From pharmacogenomics to integrated personal omics profiling: a gap in implementation into healthcareCarsten Carlberg, Hannu Raunio
Drug Metabolism and Drug Interactions|June 19, 2012
CYP2A6: genetics, structure, regulation, and functionHannu Raunio, Minna Rahnasto-Rilla
Current Drug Metabolism|November 1, 2006
The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silicoMiia Turpeinen, Hannu Raunio, Olavi Pelkonen
American Journal of Respiratory Cell and Molecular Biology|November 25, 2010
Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesisSisko Anttila, Hannu Raunio, Jukka Hakkola
Chemico-Biological Interactions|February 9, 2005
Regulation of CYP3A genes in the human respiratory tractHannu Raunio, Jukka Hakkola, Olavi Pelkonen
European Journal of Clinical Pharmacology|June 23, 2006
Use of an online surveillance system for screening drug interactions in prescriptions in community pharmaciesTiina Heikkilä, Tuula Lekander, Hannu Raunio
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2007
[Not Available]Satu Mensio, Raimo Ojala, Hannu Raunio
Clinical Pharmacokinetics|July 12, 2011
In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directionsOlavi Pelkonen, Miia Turpeinen, Hannu Raunio
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|July 21, 2011
In silico toxicology - non-testing methodsHannu Raunio
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
In vitro screening of drug metabolism during drug development: can we trust the predictions?Olavi Pelkonen, Hannu Raunio
Personalized Medicine|May 17, 2018
From pharmacogenomics to integrated personal omics profiling: a gap in implementation into healthcareCarsten Carlberg, Hannu Raunio
Drug Metabolism and Drug Interactions|June 19, 2012
CYP2A6: genetics, structure, regulation, and functionHannu Raunio, Minna Rahnasto-Rilla
Current Drug Metabolism|November 1, 2006
The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silicoMiia Turpeinen, Hannu Raunio, Olavi Pelkonen
American Journal of Respiratory Cell and Molecular Biology|November 25, 2010
Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesisSisko Anttila, Hannu Raunio, Jukka Hakkola
Chemico-Biological Interactions|February 9, 2005
Regulation of CYP3A genes in the human respiratory tractHannu Raunio, Jukka Hakkola, Olavi Pelkonen
European Journal of Clinical Pharmacology|June 23, 2006
Use of an online surveillance system for screening drug interactions in prescriptions in community pharmaciesTiina Heikkilä, Tuula Lekander, Hannu Raunio
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2007
[Not Available]Satu Mensio, Raimo Ojala, Hannu Raunio
Clinical Pharmacokinetics|July 12, 2011
In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directionsOlavi Pelkonen, Miia Turpeinen, Hannu Raunio
Pageof 7